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Introduction
Drug-coated microneedle patches are a minimally invasive technique for dermal drug
delivery. However, their formulation usually requires careful calibration of formulation
viscosity to enable fluid flow through the coating equipment at a sufficiently low viscosity,
yet promote bulk formation on the microneedle surface at a sufficiently high viscosity
[1, 2]. Clearly, an ability to manipulate the viscosity of the coating formulation during
the coating process will be advantageous. Here, we evaluate thermoreversible hydrogel
formulations as a strategy to do so, using temperature as a trigger.
Materials and methods
Methylene blue (MB, 0.5%w/w) was formulated as a model drug in poloxamer 407
(15–28%w/w) hydrogels. Sol-gel transitions were determined using rotational rheometry.
Microwells for dip-coating were produced from polydimethylsiloxane against a 3D-printed
negative template. Cold liquid MB-poloxamer formulations were pipetted into microwells
and warmed at 30°C until gelling. Polylactic acid microneedles were fabricated by
micromoulding [3] and dipped into the gelling MB-poloxamer formulations. MB loading
and in vitro release were quantified using UV/Vis spectrophotometry (λ = 665nm).
Coated microneedles and MB release in excised porcine skin were visualised by light
microscopy.
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Figure 1: (A) A microneedle coated with MB-poloxamer hydrogel formulation, and (B) En face
image of skin, captured 15 min after microneedle insertion, showing MB released
from a microneedle patch coated with a MB-poloxamer formulation. Scale bars: (A)
200µm, (B) 2mm.
Results and discussion
The MB-poloxamer formulations underwent reversible sol-gel transitions between 10–
25°C. MB incorporation did not alter the sol-gel transition temperatures of the hydrogels.
The thermoreversibility of the formulations allowed facile loading in the microwell.
Warming the formulations at 30°C rapidly increased their viscosities to promote bulk
formation on the microneedle surface (Figure 1A). Up to 2.5µg MB was loaded per 1 cm2
microneedle patch. Whilst uncoated MB-poloxamer formulations exhibited extended
release characteristics in vitro, coated formulations showed rapid release characteristics,
probably due to the smaller bulk of the coating in the latter. The microneedles released
MB within 15 min when inserted into porcine skin (Figure 1B).
Conclusion
Thermoreversible hydrogel formulations enable on-the-fly, temperature-controlled ma-
nipulation of formulation viscosity. This strategy can be used to formulate microneedle
drug coatings for minimally invasive drug delivery in the skin.
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